Concerns are mounting across Europe regarding proposals to progressively replace mandatory paper leaflets accompanying medications with digital alternatives accessible via QR codes and smartphones. Representatives from Germany’s pharmacy sector and the Social Association VdK have voiced strong opposition to a complete shift away from printed materials.
Thomas Preis, president of the German Federal Association of Pharmacists (ABDA), emphasized that while electronic leaflets can serve as a supplement to printed versions, they should not be a replacement. He underscored the importance of ensuring accessibility for all, particularly in emergency situations, pointing out that many older individuals and those with disabilities lack consistent access to digital applications. Preis also cautioned against placing additional burdens on pharmacies and doctor’s offices, who might be required to print digital leaflets onto paper.
Verena Bentele, president of the VdK, echoed this sentiment, advocating for a dual approach: providing both printed and digital leaflets to prevent anyone from being left behind. She stressed that patients should retain a legal right to receive a paper leaflet. Simultaneously, Bentele acknowledged the significant advantages electronic leaflets offer, especially for individuals with visual impairments who require accessible digital formats.
The discussions stem from ongoing efforts to reform European pharmaceutical law, with a renewed focus expected after the summer recess. The reform aims to enhance the competitiveness of the European pharmaceutical sector and bolster the continent’s medicine supply chain.
While the European Commission, European Parliament and member states broadly agree on expanding the role of electronic patient information, reservations are being raised in several EU countries, including France, where consumer and patient advocacy groups are resisting the potential disappearance of paper leaflets.
German MEP and physician Peter Liese (CDU) believes phasing out paper leaflets in favor of digital alternatives is a sensible move. He argues that such a change would facilitate the rapid transfer of medicines from other EU countries in the event of temporary shortages within a specific member state and would contribute to environmental protection by reducing paper consumption. Liese suggests that those requiring a printed copy should be able to obtain one at pharmacies, highlighting the benefits of current technological capabilities, particularly for individuals with limited knowledge of the local language.
